Nov 7 Statement | UMR Congratulates Dr. Monica Bertagnolli on her Confirmation as the next NIH Director
NIH Research 101 | UMR Answers Common Questions About NIH Research in this New Fact Sheet Series
2023 Rural State Analysis | UMR's Newest Report Reveals the Exponential Impact of NIH Research Funding in Rural States
Why Invest in NIH Research? | UMR Offers Fact Sheets Explaining Why Congress Must #keepNIHstrong

A participant in the NIH 2019-2020 Medical Research Scholars Program.

Photo Credit: National Institutes of Health

About This Photo

PhRMA CEO Steve Ubl and Sage Therapeutics CEO Barry Greene: Coming Together to Fight COVID-19

This year, the biopharmaceutical research industry has been working around the clock to combat the COVID-19 virus, including developing effective therapeutics to treat COVID-19 and vaccines to prevent future infections. A key piece of that has been the impact the pandemic has had on mental health. PhRMA CEO Steve Ubl recently had the opportunity to connect with Barry Greene, CEO of Sage Therapeutics, about the company’s efforts to address COVID-19’s impact.